ARTICLE | Clinical News
Introgen preclinical data
November 7, 2005 8:00 AM UTC
Researchers published in Molecular Therapy that, in human prostate cancer cell lines, INGN 241 significantly inhibited VEGF expression (p<0.05). INGN 241 is a modified adenoviral vector encoding the M...